Fox Run Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-9,468	Closed	-$586K	–	963
2022 Q3	$586K	Buy	9,468 +2,254	+31%	+$157K	0.23%	119
2022 Q2	$575K	Buy	7,214 +3,993	+124%	+$378K	0.29%	94
2022 Q1	$339K	Buy	+3,221	New	+$314K	0.19%	224
2020 Q4	–	Sell	-3,598	Closed	-$279K	–	312
2020 Q3	$279K	Buy	+3,598	New	+$248K	0.7%	51
2019 Q2	–	Sell	-18,449	Closed	-$488K	–	717
2019 Q1	$488K	Buy	+18,449	New	+$437K	0.28%	108
2018 Q4	–	Sell	-24,264	Closed	-$475K	–	849
2018 Q3	$475K	Buy	+24,264	New	+$461K	0.21%	194
2018 Q2	–	Sell	-28,727	Closed	-$408K	–	1029
2018 Q1	$408K	Buy	28,727 +9,527	+50%	+$141K	0.1%	387
2017 Q4	$280K	Buy	19,200 +3,400	+22%	+$47.8K	0.08%	485
2017 Q3	$200K	Sell	15,800 -10,800	-41%	-$137K	0.06%	610
2017 Q2	$316K	Buy	+26,600	New	+$331K	0.11%	388
2017 Q1	–	Sell	-12,000	Closed	-$194K	–	828
2016 Q4	$194K	Buy	+12,000	New	+$218K	0.1%	437